187 related articles for article (PubMed ID: 24730308)
1. Applications of nanomedicine in breast cancer detection, imaging, and therapy.
Saadeh Y; Leung T; Vyas A; Chaturvedi LS; Perumal O; Vyas D
J Nanosci Nanotechnol; 2014 Jan; 14(1):913-23. PubMed ID: 24730308
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine for the treatment of triple-negative breast cancer.
Kutty RV; Wei Leong DT; Feng SS
Nanomedicine (Lond); 2014 Apr; 9(5):561-4. PubMed ID: 24827837
[No Abstract] [Full Text] [Related]
3. Lipid-enveloped hybrid nanoparticles for drug delivery.
Tan S; Li X; Guo Y; Zhang Z
Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine applications in the treatment of breast cancer: current state of the art.
Wu D; Si M; Xue HY; Wong HL
Int J Nanomedicine; 2017; 12():5879-5892. PubMed ID: 28860754
[TBL] [Abstract][Full Text] [Related]
5. Current prospects and challenges of nanomedicine delivery in prostate cancer therapy.
Gupta S; Gupta PK; Dharanivasan G; Verma RS
Nanomedicine (Lond); 2017 Dec; 12(23):2675-2692. PubMed ID: 29098929
[TBL] [Abstract][Full Text] [Related]
6. Targeted nanodrugs for cancer therapy: prospects and challenges.
Bottini M; Sacchetti C; Pietroiusti A; Bellucci S; Magrini A; Rosato N; Bottini N
J Nanosci Nanotechnol; 2014 Jan; 14(1):98-114. PubMed ID: 24730253
[TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
8. Inorganic nanoparticles for predictive oncology of breast cancer.
Yezhelyev M; Yacoub R; O'Regan R
Nanomedicine (Lond); 2009 Jan; 4(1):83-103. PubMed ID: 19093898
[TBL] [Abstract][Full Text] [Related]
9. Nanoarchitectonics in cancer therapy and imaging diagnosis.
Pandey AP; Girase NM; Patil MD; Patil PO; Patil DA; Deshmukh PK
J Nanosci Nanotechnol; 2014 Jan; 14(1):828-40. PubMed ID: 24730301
[TBL] [Abstract][Full Text] [Related]
10. Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics.
de Sousa Cunha F; Dos Santos Pereira LN; de Costa E Silva TP; de Sousa Luz RA; Nogueira Mendes A
J Drug Target; 2019 Aug; 27(7):732-741. PubMed ID: 30207742
[TBL] [Abstract][Full Text] [Related]
11. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
[TBL] [Abstract][Full Text] [Related]
12. The holistic 3M modality of drug delivery nanosystems for cancer therapy.
Sun J; Luo C; Wang Y; He Z
Nanoscale; 2013 Feb; 5(3):845-59. PubMed ID: 23292001
[TBL] [Abstract][Full Text] [Related]
13. The role of nanotechnology in gastrointestinal cancer.
Vyas D; Castro P; Saadeh Y; Vyas A
J Biomed Nanotechnol; 2014 Nov; 10(11):3204-18. PubMed ID: 26000381
[TBL] [Abstract][Full Text] [Related]
14. Hybrid paclitaxel and gold nanorod-loaded human serum albumin nanoparticles for simultaneous chemotherapeutic and photothermal therapy on 4T1 breast cancer cells.
Peralta DV; Heidari Z; Dash S; Tarr MA
ACS Appl Mater Interfaces; 2015 Apr; 7(13):7101-11. PubMed ID: 25768122
[TBL] [Abstract][Full Text] [Related]
15. The role of nanotechnology in prostate cancer theranostic applications.
Cherian AM; Nair SV; Lakshmanan VK
J Nanosci Nanotechnol; 2014 Jan; 14(1):841-52. PubMed ID: 24730302
[TBL] [Abstract][Full Text] [Related]
16. Gold nanostars for efficient in vitro and in vivo real-time SERS detection and drug delivery via plasmonic-tunable Raman/FTIR imaging.
Tian F; Conde J; Bao C; Chen Y; Curtin J; Cui D
Biomaterials; 2016 Nov; 106():87-97. PubMed ID: 27552319
[TBL] [Abstract][Full Text] [Related]
17. Magnetic nanoparticles for magnetic drug targeting.
Lyer S; Singh R; Tietze R; Alexiou C
Biomed Tech (Berl); 2015 Oct; 60(5):465-75. PubMed ID: 26351783
[TBL] [Abstract][Full Text] [Related]
18. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
Pridgen EM; Langer R; Farokhzad OC
Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
[TBL] [Abstract][Full Text] [Related]
20. Perspectives of nanotechnology in minimally invasive therapy of breast cancer.
Yang Y; Wang H
J Healthc Eng; 2013; 4(1):67-86. PubMed ID: 23502250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
